Beijing Foyou Pharma (601089.SH): Diquyuntan Tablets Obtained Drug Registration Certificate.
Fukuyuan Pharmaceuticals (601089.SH) announcement, the company's wholly-owned subsidiary Zhejiang Aisheng Pharmaceutical Co., Ltd. (referred to as "Zhejiang...
Beijing Foyou Pharma (601089.SH) announced that its wholly-owned subsidiary Zhejiang Aisheng Pharmaceutical Co., Ltd. (referred to as "Zhejiang Aisheng") has received the Drug Registration Certificate for Dienogest Tablets (10mg) issued by the National Medical Products Administration, approving the production of the drug. Dienogest is a synthetic progestin that can be taken orally and absorbed by the body.
Related Articles
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
